| scholarly article | Q13442814 |
| P2093 | author name string | Senyon Choe | |
| Byung-Hak Yoon | |||
| Chihoon Ahn | |||
| Jae Hyup Lee | |||
| Byong Moon Kim | |||
| Jongho Cho | |||
| Hyun Chan Ahn | |||
| Hyosun Oh | |||
| Kyuheum Na | |||
| Jungyoun Choi | |||
| P2860 | cites work | MADR1, a MAD-related protein that functions in BMP2 signaling pathways | Q24317247 |
| An Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2 | Q27682737 | ||
| Identification of a binding site on the type II activin receptor for activin and inhibin | Q28143632 | ||
| A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned | Q28242411 | ||
| Designer TGFβ superfamily ligands with diversified functionality | Q28477811 | ||
| Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase | Q28584256 | ||
| Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data | Q30486207 | ||
| Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. | Q34406617 | ||
| Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion | Q34729247 | ||
| Bone morphogenetic proteins and spinal surgery | Q35191279 | ||
| Bone Transport for Reconstruction in Benign Bone Tumors | Q35890296 | ||
| Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. | Q36654826 | ||
| A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). | Q36885933 | ||
| Acute Intravenous Injection Toxicity Study of Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Rat | Q37717865 | ||
| Osteolysis in transforaminal lumbar interbody fusion with bone morphogenetic protein-2. | Q37827030 | ||
| A review of the methods, interpretation, and limitations of the urine drug screen | Q37952275 | ||
| Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis | Q38115448 | ||
| The use of platelet rich plasma, bone morphogenetic protein-2 and different scaffolds in oral and maxillofacial surgery - literature review in comparison with own clinical experience | Q38178269 | ||
| Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. | Q41069920 | ||
| Activin receptors: cellular signalling by receptor serine kinases | Q41275966 | ||
| Bone morphogenetic protein-2 compared to autologous iliac crest bone graft in the treatment of long bone nonunion | Q82830321 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 284-289 | |
| P577 | publication date | 2015-10-07 | |
| P1433 | published in | Drug and Chemical Toxicology | Q5308876 |
| P1476 | title | The effects of a single intravenous injection of novel activin A/BMP-2 (AB204) on toxicity and the respiratory and central nervous systems | |
| P478 | volume | 39 |
Search more.